USS to distribute Imagyn scope:
This article was originally published in Clinica
Imagyn Medical is to manufacture its 2 mm high-resolution endoscopes under the US Surgical label. As part of an agreement between the two companies, the scope will be added to USS' Minisite line of laparoscopic products marketed worldwide. Some 80% smaller than conventional laparoscopes, the 2 mm scope will compete in a market which Imagyn estimates has a potential value of $150 million. Founded in 1989, privately-held Imagyn Medical produces minimally invasive devices for use in gynaecological surgery.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.